Search for: "Genentech, Inc."
Results 21 - 40
of 469
Sort by Relevance
|
Sort by Date
12 Feb 2023, 4:00 pm
While we defer to the district court’s assessment of the average time to trial data, see Planned Parenthood, 52 F.4th at 631; In re Genentech, Inc., 566 F.3d 1338, 1347 (Fed. [read post]
28 Jan 2023, 8:09 pm
Jill Schmidt of Genentech, Inc.; Sharonmoyee Goswami of Cravath, Swaine & Moore LLP; Derek McCorquindale of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; and Angelo Oliver of Haynes & Boone, LLP will review key decisions issued by the Federal Circuit regarding patent law issues in 2022, including decisions on enablement and written description, patent damages, venue, litigation procedure, and AIA trials before the Patent Trial and Appeal... [read post]
27 Dec 2022, 7:01 pm
Sandoz Inc. [read post]
22 Dec 2022, 3:15 pm
The outcome: Genentech, Inc. and InterMune, Inc. [read post]
21 Dec 2022, 11:57 am
Genentech, Inc. v. [read post]
5 Dec 2022, 6:55 am
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
5 Dec 2022, 6:55 am
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
5 Dec 2022, 6:55 am
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
5 Oct 2022, 6:51 am
See Deprenyl Animal Health, Inc. v. [read post]
4 Aug 2022, 6:56 am
In addition, Genentech filed a lawsuit, against Amgen Inc., based on threat of indirect infringement, as Amgen Inc. would supply its Brazilian subsidiary with the infringing product. [read post]
5 Mar 2022, 6:35 pm
” Genentech, Inc. v. [read post]
24 Feb 2022, 6:12 pm
Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent — and rejecting the Federal Circuit’s reasonable-apprehension-of-suit requirement. [read post]
19 Feb 2022, 8:38 pm
Sommer of Greenberg Traurig, LLP will moderate a panel consisting of Sharonmoyee Goswami of Cravath, Swaine & Moore LLP; Derek McCorquindale of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Angelo Oliver of Haynes & Boone, LLP; and Jill Schmidt of Genentech, Inc. [read post]
8 Feb 2022, 1:54 pm
Genentech, Inc., 549 U.S. 118, 124 (2007). [read post]
3 Feb 2022, 12:43 pm
” Entegris, 490 F.3d at 1351 (quoting Genentech, Inc. v. [read post]
1 Feb 2022, 12:32 am
Regele dated 16 January 2017D50 Assignment by the inventors to Alexion Pharmaceuticals Inc. dated 28.03.2007, 02.04.2007 and 11.09.2007 respectivelyD51 Document supporting the name change from "UDEC Pharmaceuticals,Inc. to "Alexion Pharmaceuticals Inc"D52 Declaration of S. [read post]
20 Dec 2021, 8:42 am
Genentech, Inc., 549 U.S. 118 (2007) (licensee standing for declaratory judgment action); Blonder-Tongue Laboratories, Inc. v. [read post]
14 Dec 2021, 9:57 am
Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent. [read post]
10 Nov 2021, 12:15 pm
Genentech, as it asserted. [read post]
7 Nov 2021, 9:50 pm
Patent & Trademark Office, and Derek Maetzold of Castle Biosciences, Inc. [read post]
